Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand

3,4-Methylenedioxymethamphetamine (MDMA) is drug of high prevalence in Aotearoa New Zealand and is the primary drug analysed by legal drug checking services. We aimed to address the gap in literature pertainin...

Source: Harm Reduction Journal - March 21, 2024 Category: Drugs & Pharmacology Authors: Jai Whelan, Geoff Noller and Ryan D. Ward Tags: Research Source Type: research